Kenvue Inc.
Kenvue to be Acquired by Kimberly-Clark in $48.7 Billion Deal
Summary
Kenvue Inc. has entered into a definitive merger agreement to be acquired by Kimberly-Clark Corporation for an enterprise value of $48.7 billion. The transaction includes $6.8 billion in upfront cash consideration and is expected to close in the second half of 2026. Additionally, Kirk L. Perry was appointed as Kenvue's CEO, and an amendment to the Executive Severance Pay Plan was approved. The merger is anticipated to create a $32 billion global health and wellness leader.
Profitelligence Alerts
Get alerts for KVUE
Be first to know when Kenvue Inc. files with the SEC.
Filing Categories
Advertisement
About Kenvue Inc.
Kenvue Inc. is a consumer healthcare and pharmaceutical company. It focuses on delivering a range of health-centric products, spanning hygiene, pain relief, and other wellness categories. With deep-rooted expertise in pharmaceuticals, Kenvue Inc. targets the health and wellness needs of individuals, providing both prescription and over-the-counter solutions. The company has established itself as a vital entity in the consumer health sector, significantly impacting community health standards and individual lives. Positioned in the pharmaceutical industry, Kenvue Inc. collaborates with healthcare providers to enhance its product reach and efficacy. Its broad portfolio includes well-known brands and formulations that are trusted globally by consumers seeking reliable health solutions. As a player in this sector, Kenvue Inc. contributes to the enhancement of public health, highlighting its prominence in both domestic and international markets.
Official SEC Documents
Advertisement